121 related articles for article (PubMed ID: 3747259)
1. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy.
Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T
Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259
[TBL] [Abstract][Full Text] [Related]
2. [2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells obtained from patients with chronic hepatitis B during interferon therapy].
Sugawara T
Hokkaido Igaku Zasshi; 1990 Sep; 65(5):439-54. PubMed ID: 2227795
[TBL] [Abstract][Full Text] [Related]
3. Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.
Karino Y; Sugawara T; Saga A; Yoshida J; Matsushima T; Miyazaki T; Toyota J; Okuuchi Y
Gastroenterol Jpn; 1989 Apr; 24(2):164-9. PubMed ID: 2744332
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
[TBL] [Abstract][Full Text] [Related]
5. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
[TBL] [Abstract][Full Text] [Related]
6. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
[TBL] [Abstract][Full Text] [Related]
7. Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis.
Heathcote J; Kim YI; Yim CK; LeBrocq J; Read SE
Hepatology; 1989 Jan; 9(1):105-9. PubMed ID: 2461889
[TBL] [Abstract][Full Text] [Related]
8. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193
[TBL] [Abstract][Full Text] [Related]
9. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon.
Nakajima S; Kuroki T; Shintani M; Kurai O; Takeda T; Nishiguchi S; Shiomi S; Seki S; Kobayashi K
Hepatology; 1990 Dec; 12(6):1261-5. PubMed ID: 2147916
[TBL] [Abstract][Full Text] [Related]
10. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
Ogawa Y
Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
[TBL] [Abstract][Full Text] [Related]
11. Changes in 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells from patients with fulminant hepatitis.
Nishino S; Ohnishi H; Muto Y; Moriwaki H; Sakai T; Sugihara J; Saitoh K
Gastroenterol Jpn; 1989 Jun; 24(3):337. PubMed ID: 2744346
[No Abstract] [Full Text] [Related]
12. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance].
Komiyama T; Akaike M; Satomura K; Okumura H
Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348
[TBL] [Abstract][Full Text] [Related]
13. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.
Jakschies D; Zachoval R; Müller R; Manns M; Nolte KU; Hochkeppel HK; Horisberger MA; Deicher H; Von Wussow P
Hepatology; 1994 Apr; 19(4):857-65. PubMed ID: 8138257
[TBL] [Abstract][Full Text] [Related]
14. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
[No Abstract] [Full Text] [Related]
15. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases.
Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN
Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173
[No Abstract] [Full Text] [Related]
16. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G
J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase.
Nishiguchi S; Kuroki T; Otani S; Takeda T; Hirota S; Shimizu Y; Nakajima S; Saito S; Shiomi S; Kobayashi K
Hepatology; 1989 Jul; 10(1):29-33. PubMed ID: 2472340
[TBL] [Abstract][Full Text] [Related]
18. A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.
Johnston MI; Preble OT; Imai J; Jacobsen H; Torrence PF
J Immunol Methods; 1983 Dec; 65(1-2):123-35. PubMed ID: 6361140
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant leukocyte interferon on ribonuclease activities in serum in chronic hepatitis B.
Tsuji H; Murai K; Akagi K; Fujishima M
Clin Chem; 1990 Jun; 36(6):913-6. PubMed ID: 2357834
[TBL] [Abstract][Full Text] [Related]
20. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
Hirai N; Shimizu M; Morioka T; Hinoue Y; Tanaka N; Kobayashi K; Hattori N; Hashimoto T
Liver; 1988 Jun; 8(3):138-45. PubMed ID: 3393063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
